اخبار

نظرسنجي

به نظر شما در گروه فارماسيوتيکس کدام آزمايشگاه از نظر وضعيت دستگاههاي موجود و نحوه همکاري کارشناس آزمايشگاه با دانشجو مناسب تر مي باشد؟

آزمايشگاه صنعتي 46.5%
آزمايشگاه توليدي 6.8%
آزمايشگاه اشکال دارويي 6.0%
آزمايشگاه سامانه هاي نوين دارورساني 17.7%
آزمايشگاه تخصصي داروسازي 23.0%


مشاهده نتايج

صفحات پر بازديد

دانشکده داروسازی مشهد ( 316730 )
آزمایشگاه شیمی داروئي ( 57298 )
آزمایشگاه شیمی عمومي و شيمي آلي ( 56416 )
گروه شیمی دارویی ( 37385 )
دكتر جواد بهروان ( 30265 )
دکتر محمدرضا صابری ( 30144 )
چیدمان دروس رشته داروسازی ( 28626 )
پیام های هفتگی مرکز مشاوره ( 26244 )
سنتز ترکيبات دارويی ( 25472 )
واحد تحصیلات تکمیلی ( 24079 )
آیین نامه آموزشی دوره دکتری عمومی داروسازی واحدهاي درسي و طول مدت تحصيل ( 22720 )
سیستم های دارورسانی نوین ( 21792 )
دکتر فرزین هادیزاده ( 17962 )
آزمایشگاه آنالیز دستگاه و عكس ( 17793 )
دكتر محمد رمضاني ( 17777 )
ریاست دانشکده داروسازی دکتر محسن ايمن شهيدي ( 16645 )
دكتر حسين حسين زاده ( 15994 )
دکتر بی بی صديقه فضلی بزاز ( 15649 )
معرفی دانشجویان برتر دانشکده داروسازی ( 15614 )
ليست دروس دانشكده داروسازي ( 15163 )
دكتر سيد عادل معلم ( 14338 )
بیوانفورماتیک ( 14231 )
دکتر محمود رضا جعفری - گروه فارماسیوتیکس ( 13633 )
کتابخانه دانشکده داروسازی مشهد ( 13209 )
سلولهای بنیادی ( 13056 )

 

 

دکتر جواد بهروان > فعاليتهاي تحقيقاتي

 

رزومه
Curriculum Vitae

1) مشخصات فردي

نام : جواد
نام خانوادگي: بهروان
جنسيت: مرد
رشته تحصيلي: بیوتکنولوزی دارویی
گروه آموزشي: بیوتکنولوژی دارویی
مرتبه علمي: استاد
آدرس محل كار: دانشکده داروسازی-پردیس دانشگاه
تلفن محل كار: 8823255(98511+)
آدرس پست الكترونيك: behravanj@mums.ac.ir

2) تحصيلات دانشگاهي

1) داروسازی عمومي، دانشگاه علوم پزشكي مشهد، (1364 لغايت 1370)
2) دکتری تخصصی PhD دانشگاه شفیلد کشور انگلستان (1374 لغلیت 1378)
 
 
3) تجربيات حرفه اي
1) استادیار دانشگاه علوم پزشکی مشهد، (خرداد 1378 لغايت آبان ماه 1382)
2) دانشیار دانشگاه علوم پزشکی مشهد (آبان ماه 1382 لغایت مرداد ماه 1387)
3) استاد دانشگاه علوم پزشکی مشهد (مرداد ماه 1387 تا کنون)

4) تجربيات آموزشي

1) تدریس فراورده های بیولوژیک و زیست شناسی مولکولی داروسازی دانشگاه علوم پزشکی مشهد، (از نیمسال اول 1370 تا کنون)
2) تدریس دروس دوره تخصصی بیوتکنولوژی دارویی دانشگاه علوم پزشكي مشهد، (مهرماه ماه 1380 تا کنون)

5) عناوين و امتيازات ويژه

1) رتبه اول در گروه داروسازی، جشنواره هفته پژوهش دانشگاه علوم پزشكي مشهد سال 1389

6) فعاليت هاي پژوهشي

الف) انتشار مقاله در ژورنال‎هاي علمي پژوهشي سطح ISI) :  I)
 

1. Mosaffa, F., Kalalinia, F., and Behravan, J (2012). Pro-inflammatory Cytokines Interleukin-1 beta, Interleukin 6 and Tumor Necrosis Factor-alpha Alter the Expression and Function of ABCG2 in Cervix and Gastric Cancer Cells. Molecular and cellular biochemistry (In press).

2.Entezari, Hadizadeh, F., Sankian M., Tavakol Afshari, J and Behravan, J. (2012). Cyclooxygenase-2 inhibition by novel Bisaryl imidazolyl imidazole derivatives increases Bax/Bcl-2 ratio and upregulates Caspase-3 gene expression in Caco-2 colorectal cancer cell line. Genes and Genomics (In press).

3.Shamsara J, Mohammadpour AH, Behravan J, Falsoleiman H, Ramezani M.(2011). Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients. Immunopharmacol. Immunotoxicol. Epub ahead of print. (IF: 1.209).

4.Hassany, M., Hassanzadeh, M.K., Behravan, J. and Kasaeian, J. (2011). Expression of Drug Pump Protein MRP2 in Lipopolysaccharide-Treated Rats and Its Impact on the Disposition of Acetaminophen. Iranian J. Pharmacuet. Res. (in press). (IF:0651)

5.Behravan J, Mosafa F, Soudmand N, Taghiabadi E, Razavi BM, Karimi G.(2011).Protective Effects of Aqueous and Ethanolic Extracts of Portulaca oleracea L. Aerial Parts on H2O2 induced DNA Damage in Lymphocytes by Comet Assay.J Acupunct Meridian Stud. 4(3):193-7. (

6.Jamialahmadi, K., Behravan, J., Najafi, M.F., Yazdi, M.T., Shahverdi, A.R., Faramarzi, M.(2011). Enzymatic production of N-Acetyl-D-Glucosamine from chitin using crude enzyme preparation of aeromonas sp. PTCC1691. Biotechnology. 10(3): 292-297.

7.Mohajeri, S. A., Kasaian, J., Motamedi, V., Hassani, M., Behravan, J. (2011). Quantitative analysis of Methotrexate and its application in pharmacokinetic study of drug in rat serum samples. Pharmacologyonline. 2:597-604.

8.Entezari Heravi, R., Hadizadeh, F., Sankian, M., Tavakol Afshari, J., Taghdisi, M., Jafarian, H., Behravan, J (2011). Novel selective Cox-2 inhibitors induce apoptosis in Caco-2 colorectal carcinoma cell line. Eur. J. Pharm. Sci. E-pub ahead of print.(3.291).

9.Shamsara, J., Behravan, J., Falesoleiman, H., Mohammadpour, A.R. and Ramezani, M. (2011). Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients. Immunopharmacology and Immunotoxicology. In press. (1.209).

10. Namvar, F., Mohamed, S., GhasemiFard, S., Behravan, J., Mustapha, N.M., Alitheen, N.B.M., Othman, F.(2012). Polyphenol-rich seaweed (Eucheuma cottonii) extract supresses breast tumor via hormone modulation and apoptosis induction. Food Chemistry. 130 (2): 376-382. (3.458).

11. Salmasi, Z.,Ramezani, M.,Noghabi, Z.S.,Behravan, J. (2011). Euphorbia microsciadia percolatio ad Soxhlet extracts exhibit antiviral activity. Pharmacologyonline 1: 910-920.

12.Hanafi-Bojd, MY., Iranshahi, M., Mosaffa, F., Omidvar Tehrani, S., Kalalinia, F. and Behravan, J. (2011). Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein mediated rhodamine efflux in breast cancer cell lines. Planta Medica. 77(14):1590-3. (2.369).

13.Hosseinzadeh, L., Behravan, J., Mosaffa, F., Bahrami, G., Bahrami, A., Karimi, G. (2011). Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species. Food Chem Toxicol. 49(5):1102-9. (2.602)

14.Behravan, J., Ramezani, M., Fani Nobandegani, E., Ehtesham Gharaee, M. (2011). Antiviral and antimicrobial activity of Thymus transcaspicus Essential oil. Pharmacologyonline 1: 1190-1199.

15.Hosseinzadeh, H., Behravan, J., Ramezani, M., Sarafraz, S., Taghiabadi, E. (2011). Sudy of antitumor effect of methanolic and aqueaous extracts of Allium sativum (garlic)cloves using potato disc bioassay. Pharmacologyonline 1: 881-888.

16.Shamsara, J., Behravan, J., Falesoleiman, H., Mohammadpour, A.R. and Ramezani, M. (2011). Pentoxifylline administration changes protein expression profile of coronary artery disease patients. Gene. 487(1):107-11. (2.266).

17.Mosaffa, F., Kalalinia, F, Parhiz, H. and Behravan, J. (2011). TNF-α induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared to their drug-sensitive parental line. DNA and cell Biology. 30(6):413-8. (2.159)

18.Kasaian, J., Behravan, J., Hassany, M., Emami, S. A., Shahriari, F., and Hassanzadeh, M.K., (2011). Molecular Characterization & RAPD Analysis of Juniperus species from Iran. Genetics and Molecular Research. 10(2): 1069-1074. (0.796).

19.Assali, A., Behravan, J., Paydar, R., Mouhebati, M., Hassani, M., Kasaeyan, J., Tatari, F., Tavallaie, S., Sahebkar, A., Oladi, M. R., Azimi-Nezhad, M., Ghayour-Mobarhan, M., Esmaeily, H. A., Ferns, G. (2011). Association of Angiotensin II Type 1 Receptor Gene A1166C Polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease. Eur. J. Intern. Med. 22:254-261.

20.Hoseinzadeh, L., Behravan, J., Mosaffa, F., Bahrami, G., Bahrami, A. R., and Karimi, G. (2011). Effect of curcumin on doxorubicin induced cytotoxicity in H9c2 cardiomyoblast cells. Iranian J. Basic Med. Sci. 14(1):49-56.

21.Ebrahimi, M., Ramezani, M., Malekshah, O. M., Omidvar Tehrani, S. and Behravan, J. (2011). Cytotoxic Effects of Methanolic Extract and Essential Oil of Artemisia kopetdaghensis. J Essential Oil Bearing Plants. 13 (6):732-737.

22.Sabouri,S., Ghayour-Mobarhan, M., Mouhebatic,M., Hassani, M, Kassaeian, J., Tatari, A., Mahmoodi-kordi, F., Esmaeili, H. , Tavallaie, S., Paydar, R., Sahebkar,A, Omidvar Tehrani, S., Ferns, G. and Behravan, J. (2011). Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. TheScientifcWorldJournal. 11:93-101.

23.Rassouli, F.B., Matin, M.M., Iranshahi, M., Bahrami, A.R., Behravan, J., Mollazadeh, S., Neshati, V., Kalalinia, F. (2010). Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin.Toxicol in vitro. 25 (2):469-74

24.Malekshah, O. M., Bahrami, A. R., Tavakol Afshari, J., Mosaffa, F., Behravan, J. (2011). Correlation between PXR and ABCG2 patterns of mRNA expression in MCF7 breast carcinoma cell derivatives upon induction by proinflammatory cytokines. DNA and Cell Biology. 30(1): 25-31.

25.Kalalinia, F., Elahian, F., Behravan, J. (2011). Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J. Canc. Res. Clin. Oncol. 137: 321-330.

26.Kasaian, J., Hassany, M., Omidvar Tehrani, S. and Behravan, J. (2011). Evaluation of expression of drug transporter MRP2 in inflammation and its impact on the disposition of acetaminophen. Iranian Journal for Pharmaceut. Res. (in press).

27.Entezari Heravi, R., Ramezani, M., Behravan, J. (2010). Association between nicotine metabolism and CYP2A6*1 and CYP2A6*4 genotypes in an Iranian population. DNA and Cell Biol. 29 (7): 369-73.

28.Alavi-Shahri, J. Behravan, J., Hassany, M., Tatari, F., Kasaian, J., Ganjali, R.,Tavallaie, S., Sabouri, S., Sahebkar, A., Oladi, M., Mirhosseini, N., Shakeri, M. T., Montaser-Kouhsari,S., Omidvar Tehrani, S., Ghayour-Mobarhan, M., Visvikis-Siest, S., and Ferns, G. (2010). Association Between Angiotensin II Type 1 Receptor Gene Polymorphism and Metabolic Syndrome in a Young Female Iranian Population. Archives of Medical Research. 41(5):343-9.

29.Assali, A., Behravan, J., Paydar, R., Mouhebati, M., Hassani, M., Kasaeyan, J., Tatari, F., Tavallaie, S., Sahebkar, A., Oladi, M. R., Azimi-Nezhad, M., Ghayour-Mobarhan, M., Esmaeily, H. A., Ferns, G. (2010). Association between angiotensin II type-1 receptor A1166C polymorphism and the presence of angiographically-defined coronary artery disease in an Iranian population. Asian Biomedicine 4 (2): 307-314

30.Khedri A, Nejat-Shokouhi A, Salek R, Esmaeili H, Mokhtarifar A, Entezari Heravi R, Tatari F, Behravan J, Miladpour B, Omidvar Tehrani S.(2010). Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Molecular Biology reports (E-pub ahead of print).

31.Soltani, F., Mosaffa, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F, Behravan, J. (2010). Auraptene from Ferula szowitsiana Protects Human Peripheral Lymphocytes Against Oxidative Stress. Phytotherapy Research. 24(1):85-9.

32.Sabahi, Z., Salek, R, Entezari Heravi, R and Behravan, J. (2010). Association of the gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J. Cancer . 47 (3): 317-21.

33.Taghdisi, SM, Abnous, K., Mosaffa, F and Behravan, J. (2010). Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer. J. Drug Targeting . 18 (4): 277-81.

34.Elahian, F., Kalalinia, F.,Behravan, J.(2010). Evaluation of indomethacin and dexamethasone effects on BCRP mediated drug resistance in MCF-7 parental and resistant cell lines. Drug and Chemical Toxicol. 33 (2): 113-9. IF:1.409

35.Elahian, F.;Kalalinia, F.;Behravan, J. (2009). Dexamethasone Downregulates BCRP mRNA and Protein Expression in Breast Cancer Cell lines. Onc. Res. 18 (1): 9-15.

36.Iranshahi M, Noroozi S, Behravan J, Karimi G, Schneider B. (2009). Persicasulphide C, a new sulphur-containing derivative from Ferula persica.Nat Prod Res.23(17):1584-8.

37.Tatari, F., Salek, R., Mosaffa, F. and Behravan, J. (2009). Association of C3435T single nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian Population. DNA and Cell Biology. 28(5): 259-263.

38.Mosaffa, F., Lage, H., Tavakol Afshari, J and Behravan, J. (2009). Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflammation Research 58:669-676.

39.Shamsara, J., Sharifa, S., Afsharnezhad, S., Lotfi, M., Raziee, H.R., Ghaffarzadegan, K., Moradi, A., Rahighi, S., Behravana, J. (2009). Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Cancer Investigation. 27(8):825-9.

40.Neshati, V.,Matin, M.M., Iranshahi, M., Bahrami, A.R., Behravan, J.,Behnam

41. Rassouli, F., Mollazadeh, S. and Behnam Rasouli, F. (2009). Cytotoxicity of Vincristine on the 5637 Cell Line Is Enhanced by Combination with Conferone. Z. Naturforsch. 64 c, 317 – 322.

42.Soltani, F., Mosaffa, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F, Behravan, J. (2009). Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress. Cell Biol and Toxicol 25(3):291-6.

43.Noroozi, S., Mosaffa, F., Soltani, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F, Behravan, J. (2009).Antigenotoxic Effects of the Disulfide Compound Persicasulfide A (PSA) on Rat Lymphocytes Exposed to Oxidative Stress. Planta Med. 75:32-36.

44.Kalalinia, F.,Behravan, J.,Ramezani, M., Hassanzadeh, M. K., Asadipour, A. (2008). Chemical Composition, Moderate In Vitro Antibacterial and Antifungal Activity of the Essential Oil of Pistacia vera L. and it’s Major Constituents Journal of Essential Oil Bearing plants.11 (4): 376 -383.

45.Ramezani, M., Behravan, J., Arab, M., Amel Farzad, S. (2008). Antiviral activity of Euphorbia helioscopa extract. J. Biol. Sciences. 8 (4): 809-13.

46.Jami al Ahmadi, K., Tabatabaei Yazdi, M., Fathi Najafi, M., Faramarzi, M. A., Zarrini, G., Shahverdi, A., Behravan, J. (2008). Optimization of Medium and Cultivation Conditions For Chitinase Production by the Newly Isolated: Aeromonas sp. Biotechnology. 7(2): 266-272.

47.Behravan, J., Hemayatkar, M.,Toufani, H., Abdollahian, E. (2008). Linkage and assiciation of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. Archives Iranian Med. 11 (3): 252-256.

48.Behravan, J., Piquette-Miller, M.(2007). Drug transport across placenta, role of the drug efflux transporters. Expert opinion in drug metabolism and toxicity. 3 (6): 819-830.

49.Hadizadeh, F., Moradi, A., Naghibi, G., Vojdani, M., Behravan, J., Ramezani, M. (2007). Synthesis and antitumor activity of substituted succinamides using a potato disc tumor induction assay. Int. J. Biomed. Sci. 3 (1): 60-64.

50.Behravan, J.,Ramezani, M., Hassanzadeh, M. K., Ebadi, S. (2007). Evaluation of antibacterial activity of the essential oils of Zataria multiflora, Carum copticum and Thymus vulgaris by a thin layer chromatography- bioautography method. Journal of Essential Oil Bearing plants.10 (3): 259 -264.

51.Behravan, J.,Ramezani, M., Hassanzadeh, M. K., Eskandari, M., Kasaian, J., Sabeti, Z. (2007).Composition and antimicrobial activity of Ziziphora clinopodioides Lam. essential oil from Iran. Journal of Essential Oil Bearing plants.10 (4): 339-345.

52.Jaafari, M. R., Behravan, J., Abde-Emami, J., Saghafi-Khadem, F., Ramezani, M. (2006). Evaluation of leishmaniciadal effects of Euphorbia bungei Boiss extract by in vitro leishmanicidal assay using promastigotes of Leishmania major. Int. J. Pharmacol Vol. 2 (5): 571-5.

53.Mosaffa, F.,Behravan, J., Karimi, G., Iranshahi, M. (2006). Antigenotoxic effects of Satureja hortensis L. on rat lymphocytes exposed to oxidative stress. Arch. Pharm. Res. 29 (2): 159-164.

54.Gedeon, C.,Behravan, J., Piquette-Miller, M., Koren, G. (2006). Transplacental transport of glyburide and its implications for treatment of gestational diabetes. Placenta 27(11-12):1096-102.

55.Behravan, J., Naghibi, M., Mazloumi, M.A., Hassany, M. (2006).Polymorphism of angiotensin II receptor type 1 gene in essential hypertention in an Iranian population. Daru 14 (2): 82-86.

56.Jaafari, M. R., Behravan, J., Bodaghabadi, A., Ramezani, M. (2006). Evaluation of leishmaniciadal effects of Euphorbia myrsinites extract by in vitro leishmanicidal assay using promastigotes of Leishmania major. Iranain J. Basic Med. Sci. Iranian J. Basic Med. Sci. (IJBMS) Vol. 8 (4).pp 295-8.

57.Ramezani, M., Behravan, J., Yazdinezhad, A. (2006). Composition and antimicrobial activity of volatile oil of Artemisia koptdaghensis Krasch., M. Pop. & Linecz ex Poljak from Iran. Flavour and Fragrance Journal. Vol. 21 (6): 421-423.

58.Behravan, J.,Ramezani, M., Hassanzadeh, M. K., Elispour, N., Sabeti, Z. (2006).Cytotoxic and antimycotic activities of essential oil of Artemisia turanica Krasch from Iran.Journal of Essential Oil Bearing plants.9 (2):196-203.

59.Behravan, J., Fazli Bazzaz, B.S., Malaekeh, P. (2005). Survey of Bacteriological contamination of cosmetic creams in Iran. Int. J. Dermatol. 44: 482-485.

60.Hosseinzadeh, H.,Behravan, J., Ramazani, M., Ajgan, Kh. (2005). Anti-tumor and cytotoxic evaluation of Crocus sarivus L. stigma and petal extracts using brine shrimp and potato disc assays. Journal of Medicinal Plants. Vol. 4 (15): 59-65.

61.Hosseinzadeh, H.,Behravan, J., Ramazani, M., Zargarnia, Z. (2005). Antitumor activity of adenosine and cyclohexyladenosine using potato disc assay. Iranain J. Basic Med. Sci. (IJBMS) Vol. 8 (1).pp. 13-17.

62.Behravan, J., Ahmadpour, H. (2004). Cloning and characterization of directly amplified antiviral gene interferon alpha-2b (HuIFNa-2b) from human leukocytes chromosomal DNA. Arch. Pharm. Res. 27 (7):776-780.

63.Behravan, J. Rangsaz, Z. (2004).Detection and characterization of b-lactam resistance in Bacillus cereus. TheScientificWorldJOURNAL. 4:622-27.

64.Behravan, J., Ramezani, M, Kasaian, J., Sabeti, Z. (2004). Antimycotic activity of the essential oil of Satureja mutica Fish & C. A. from Iran. Flavour and Fragrance Journal. 19 (5): 421-423.

65.Ramezani, M., Behravan, J., Yazdinezhad, A. (2004). Chemical composition and antimicrobial activity of volatile oil of Artemisia khorasanica Podl. from Iran. Pharmaceutical Biology. 42 (8): 599-602.

66.Behravan, J., Fazly Bazzaz, B. S., Salimi, Z. (2003). Optimization of dextran production by Leuconostoc mesentroides NRRL B-512 using cheap and local sources of carbohydrate and nitrogen. Biotechnol. Appl. Biochem. 38 (3): 267-269.

67.Moir, A., Corfe, B. M., and Behravan, J. (2002) Spore germination. Cell. Mol. Life Sci. Vol. 59 (3):403-409.

68.Behravan, J., Ramazani, M., Malakzadeh, E. (2002). Evaluation of antitumor activity of two synthetic sulfonamides, XSF and SSF by a potato disc assay. Iranian J. Basic Med. Sci. (IJBMS) Vol. 5 (3): 135-9.

69.Behravan, J., Ramazani, M., Heidari, A. (2002). Screening of organisms isolated from different places in Mashhad, Iran for antibiotic production by a cross-streak method. Iranain J. Basic Med. Sci. (IJBMS) Vol. 5 (1): 12-16.

70.Behravan, J., Moir, A. (2002). Cloning of partially digested fragments of Bacillus cereus chromosomal DNA in bacteriophage lambda, construction of a lZAP DNA library. Iranain J. Basic Med. Sci. (IJBMS) Vol. 4 (4): 201-206.

71.Tackray, P.D., Behravan, J., Southworth T. W. & Moir, A. (2001). GerN, an antiporter homologue important in germination of Bacillus cereus endospores. J. Bacteriol. Vol. 183 (2): 476-482.

72.Behravan, J., Chirakkal, H., Masson, A. & Moir, A. (2000). Mutations in the gerP locus of Bacillus subtilis and Bacillus cereus affect access of germinants to their target in spores. J. Bacteriol. Vol. 182 (7). pp.1987-1994.

73.Behravan, J., Moir, A. (2000). Identification, cloning and sequencing of the hexacistronic gerP operon from Bacillus cereus. Iranian J. Basic Med. Sci. (IJBMS)Vol. 2(3).pp.127-138.

74.Behravan, J., Moir, A. (2000). PCR amplification, cloning and molecular characterization of a grmA homologues gene which has high homology to sodium-proton antiporter (napA) gene of Enterococcus hirea. Iranian J. Basic Med. Sci. (IJBMS).Vol. 3(1).pp 45-51.

75. Fazly Bazaz, B.S., Behravan, J., Nabizade, M. (2000). Formation of Bacillus subtilis biofilm on pharmaceutical packaging surfaces. Iranian J. Basic Med. Sci. (IJBMS) Vol. 3(1).pp.20-26.

 
 
 
ب) انتشار مقاله در ژورنال‎هاي علمي پژوهشي سطح Index Medicus, Pubmed, Medline) :  II )

1. Salmasi, Z.,Ramezani, M.,Noghabi, Z.S.,Behravan, J.(2011). Euphorbia microsciadia percolatio ad Soxhlet extracts exhibit antiviral activity. Pharmacologyonline.

2. Hosseinzadeh, H., Behravan, J., Ramezani, M., Sarafraz, S., Taghiabadi, E. (2011). Sudy of antitumor effect of methanolic and aqueaous extracts of Allium sativum (garlic)cloves using potato disc bioassay. Pharmacologyonline 1: 881-888.

3. Lotfi, M., Afsharnezhad, S., Raziee, H. R., Ghaffarzadegan, K., Sharif, S., Shamsara, J., lary, S., Behravan, J.(2011). Immunohistochemical assessment of MGMT expression and p53 mutation in glioblastoma multiforme. Tumori. 97:104-108.

4. Shamsara J., Behravan, J. (2010). A mechanism for tamoxifen-induced cancer" Pharmacology online. 2 (226-230).

5. Namvar, F., Mohamed, S.,Behravan, J., Mustapha, N.M., Alitheen, N.B.M., Othman, F. (2009). Estrogenic activity of Elaeis guineensis leaf. Pharmacologyonline, 2, 818-26.

6.Behravan, J., Ramezani, M., Alidoost, H. and Ehtesham Gharaee, M. (2010). Evaluation of antiphage CP51 effect of Euphorbia myrcinites by a plaque reduction ssay. Pharmacologyonline. 2, 788-797.

ج) انتشار مقاله در ژورنال‎هاي علمي پژوهشي سطح  Scopus, Chemical Abstract, Embase, Biological Abstract) :  III )

1. Asili, A., Behravan, J., Naghavi, M. R., Asili, J.(2010). Genetic diversity of Persian shallot (Allium hirtifolium) ecotypes based on morphological traits, allicin content and RAPD markers. Open Access Journal of Medicinal and Aromatic Plants. 1(1): 1-6.

2. Behravan, J., Hosseinzadeh, H., Rastgoo, A., Malekshah, O.M.A., Hassany (2010). Evaluation of Cytotoxic activity of crocin and safranal using potato disc assay and brine shrimp assay. Physiology and Pharmacology Journal. 13 (4): 397-403.

3. Miladpour, B., Nejat Shokouhi, A., Shirdel, A., Entezari Heravi, R., Banihashem, A., Esmaeili, H., Khedri, A., andBehravan, J. (2009). Association of Acute Lymphoblastic Leukemia and MDR1 Gene Polymorphism in an Ethnic Iranian Population. Iranian J Blood and Cancer. 1 (2): 5-9

4. Javidi, M., Behravan, J., Goodarzi, M., Bagherpoor, Z.(2007). An in vitro evaluation of antimicrobial activity of NaClO and chlorhexidine as intrcanal irrigants on Streptococcus focalis. Journal of Mashhad Dental School. 31(3):177-82.

5. Jami al Ahmadi, K., Tabatabaei Yazdi, M., Fathi Najafi, M., Faramarzi, M. A., Zarrini, G., Shahverdi, A., Behravan, J. (2008). Isolation and characterization of a chitionolytic enzyme producing microorganism, Paenibacillus chitinolyticus JK2 from Iran Research Journal of Microbiology. 3(6): 395-404.

7. Behravan, J., Mosaffa, F.,Karimi, G., Iranshahi, M.(2007). In vitro protective effects of Satureja hortensis essential oil and ethanolic extract on Leukocyte DNA. Journal of Medicinal Plants. 6 (22): 64-70.

8. Tavakoli Afshari, J., Zamani, A.,Behravan, J., Shisheian, B. and Seifi, B. (2003). Semi-quantitative determination of Interferon gamma mRNA by RT-PCR. Scientific Journal of Hamadan University of Medical Sciences and Health Services. 28 (2): 5-11.

و) ارائه مقاله دركنگره ها يا سمينارهاي خارجي:

1. Reza Entezari Heravi, Farzin Hadizadeh, Jalil Tavakol Afshari, Mojtaba Sankian and Javad Behravan. Synthesis and activity of new analogs of selecoxib as cyclooxygenase 2 (COX-2) inhibitors. 93rd Canadian Chemistry Conference and Exhibition . May 29 –June 2, 2010. Toronto. Canada.

2.Karimi, G.,Behravan, J., Hosseinzadeh, L., Mosaffa F.Effects of crocin on doxorubicin cytotoxicity in H9C2 cells. International Symposium on Saffron. Mashhad, Iran, May, 13-14,2009.

3.Behravan, J., Nejat Shokouhi, A. , Esmaeili, H., Banihashem, A., Shirdel, A., Miladpour, B. Association between the C3435T polymorphism of the human multidrug resistance gene (MDR1) with acute lymphoblastic leukemia. National Biotechnology Congress of AAPS. Toronto, Canada, June 21-25, 2008.

4. Raziee Hamid Reza, Afsharnejad Sima, Ghaffarzadegan Kamran, Laari Sara, Sharif Samaneh, Behravan Javad. A Comparative Immunohistochemistry of MGMT and p53 in Glioblastoma. Clinical Oncology Congress, 12-14 November 2008, Mashhad, Iran

5.Behravan, J., Fazly Bazzaz, B.S., Bahae, R.Evaluation of Interaction of Parabens with Glycerol and Propylene Glycol against Candida albicans and Aspergilus niger. American Society for Microbiology, General 107th meeting. Toronto, Canada, May 21-25,2007.

6.Behravan, J.,Ramezani, M., Hassanzadeh, M. K., Elispour, N., Sabeti, Z. Cytotoxic and antimycotic activities of essential oil of Artemisia turanica Krasch from Iran.SBS 13thAnnual conference and exhibition. Montreal, Canada, April 15-19, 2007.

7.Behravan, J., Jami-Ahmadi, K., Tabatabei, M. Fathi Najafi, M. Characterization and Optimization of Chitinase Production from Novel Chitinolytic Bacterial Isolates. 23rd International Carbohydrate Symposium. Whistler, BC, Canada, July 23-28, 2006.

8.Behravan, J., Ramezani, M., Doulatabadi, M. Evaluation of antimicrobial resistance of biofilm producing cells of Pseudomonas aeruginosa to essential oil of Pistacia vera oleoresin. The World Congress on Industrial Biotechnology and Bioprocessing. Toronto, Canada, July 11-14, 2006.

9.Behravan, J., Gideon, C., Koren, G., Piquette-Miller, M. Breast Cancer Resistant Protein (BCRP) is involved in the disposition of the hypoglycemic drug, glyburide. Canadian Society for Pharmaceutical Sciences, 8th Symposium. Toronto, Canada, May 30-June 2, 2005.

10.Gedeon, C.,Behravan, J., Piquette-Miller, M., Koren, G. Transplacental transport of glyburide and its implications for treatment of gestational diabetes. 2nd Annual Canadian Therapeutic Congress. Vancouver, B.C., Canada, April 15-19, 2005.

11.Behravan, J., Ramezani, M., Eliaspour, N. Antitumor activities of methanolic extract and essential oil of Artemisia turanica by a potato tumor disc inhibition method. Pharmaceutical Sciences World Congress (PSWC 2004). Kyoto, Japan, May 29-June 3, 2004.

12.Behravan, J., Rangsaz, Z. Isolation and characterization of b-lactamase enzyme from cultures of Bacillus cereus. 11th European Congress on Biotechnology. Basel, Switzerland, August, 24-29, 2003.

13.Behravan, J., Ramezani, M., Ebadi, S. Evaluation of essential oils of Thymus vulgaris, Zataria multiflora, Carum copticum, and an extract of Ziziphora clinopodioides for antibacterial activity. 50thAnnual Congress of the Society for Medicinal Plant Research. Barcelona, Spain, Septemeber, 8-12, 2002.

14.Behravan, J., Fazly Bazzaz, B.S., Salimi, Z. Optimization of dextran production by Leuconostoc mesentroides NRRLl-B512 using cheap and local sources of carbohydrate and nitrogen. 62nd International Congress of FIP. Nice. August, 31-September 5, 2002.

15.Behravan, J., Ramezani, M., Ebadi, S. Bioautographic detection of antibacterial activity of some Iranian plants. XXVIth International Horticultural Congress. Toronto, Canada, August 11-17, 2002.

16.Behravan, J., Fazly Bazzaz, B.S., Baha, R. Evaluation of interaction of the methyl and propyl parabens with propylen glycol against Candida albicans (ATCC 10231) and Aspergilus niger (ATCC 16404). 61st International Congress of FIP. Singapore. Sept. 1-6, 2001.Behravan, J., Fazly Bazzaz, B.S., Malaekeh, P. Microbiological quality control studies on cosmetic creams of Iranian market. 61st International Congress of FIP. Singapore. Sept. 1-6, 2001.

7) كتب تأليف/ ترجمه شده

الف) كتب تأليف شده:

1.Behravan, J., Piquette-Miller, M. (2006). Role of ABC drug efflux transporters in placenta. In: Edwin C. Hearns (Ed.), Trends in Biotechnology Research, Nova Publishers, NY, USA. pp. 251-266.

2. Kalalinia, F., Mosaffa, F., andBehravan, J. (2011). MCF-7 Breast Cancer Cell Line, a Model for the Study of the Association Between Inflammation and ABCG2-Mediated Multi Drug Resistance. In: Gunduz, M., and Gunduz, S., (Ed.), Focusing Tumor Microenvironment, Stem cells and Metastasis, Intech Publishers. 343-358.

 

ب) كتب ترجمه شده:

1) Behravan, J. (2008). Molecular Biotechnology a practical approach (Persian). Volume 2, Mashhad University of Medical Sciences Press. Mashhad. Iran.

2) Behravan, J. (2003). Molecular Biotechnology a practical approach (Persian). Volume 1, Mashhad University of Medical Sciences Press. Mashhad. Iran.

 
 
8) مسئولیت های اجرائی
 
1) مدیر گروه بیوتکنولوزی دارویی از 1384لغایت 1389
2) رییس مرکز تحقیقات بیوتکنولوژی از 1384 لغایت 1389
 

9) عضویت در سازمان ها

1) عضو مرکز تحقیقات بیوتکنولوزی دانشگاه

 
10) علایق پژوهشی
 
1-بیولوزی مولکولی مقاومت دارویی در سرطان
2- سلولهای بنیادی
3- نمایش سطحی فاژ و کاربرد آن در طراحی واکسن ها
 
 
 
 
 
 
 
 
 
 

تاريخ بروز رساني : دوشنبه 11/10/91 ساعت 07:23

Mashhad University of Medical Sciences Contact Details:
Main address: University St., Ghoraishy Building 91375-345 Mashhad, Iran ,
Tel:( 98 511) 841 2081-5 , Fax:( 98 511) 8430249 , E-mail: Info(at)mums.ac.ir Members: - Schools and Hospitals School: Dentistry , School: Health , School: Medicine , School: Nursing & Midwifery , School: Paramedical , School: Pharmacy , School: Traditional Medicine , Hospital: Dr.Sheikh , Hospital: Dr.Shariati , Hospital: Emam Reza , Hospital: Ghaem , Hospital: Hashemi Nezhad , Hospital: Ibn-e-Sina , Hospital: Khatam-al-Anbia , Hospital: Montaserie , Hospital: Ommul-Banin , Hospital: Omid , Hospital: Shahid Kamyab , Hospital: Taleghani , History: Mashhad Faculty of Medicine was officially opened on Nov. 23, 1949 by Dr Zanganeh, the minister of culture. The school started out with 61 students, one associate professor and seven tutors. In 1956, when the school of Arts opened, the two schools merged to form the University of Mashhad. In 1989, the faculties offering Medical Sciences' degrees across the country separated from the Ministry of Culture and Higher Education. New emerging Medical Universities have gone under management of Ministry of Health, Treatment and Medical Education. Thus the original University of Mashhad was divided into two independent universities: "Ferdowsi University of Mashhad" and "Mashhad University of Medical Sciences'. Mashhad University of Medical Sciences operates at present with 8 faculties, 32 hospitals, 179 rural and 147 urban health centers. It covers an enormous area stretching from the north east to the central parts of the country, which makes it the largest university of Medical Sciences providing health care and treatment services. With 597 teaching staff, 1645 MDs with different specialties, 138 dentists, 123 pharmacists and 25, 402 employees, the university provides health care and medical services to the area's large population as well as to over 25 million tourists a year.

مشهد، میدان آزادی، پردیس دانشگاه فردوسی، دانشکده داروسازی صندوق پستی: 1365-91775 تلفن: 66-8823255 511 نمابر: 8823251 511 پست الکترونیک: phs.it@mums.ac.ir
تمام حقوق مادی و معنوی این سایت مربوط به دانشگاه علوم پزشکی مشهد می باشد و هرگونه کپی برداری از مطالب آن تنها با ذکر منبع بلامانع است .

آدرس سایت جدید دانشکده : pharmacy.mums.ac.ir